A theme involving the acquisition of GeneSoC, an ultra-fast genetic quantification technology, together with related instruments and infectious disease detection kits through the acquisition of ジェイタス, strengthening the infectious disease treatment and diagnostics businesses. It also includes the subsequent product rollout of the pertussis detection kit and GeneSoC mini 2.